No clear answer
Integrin blockade (lymphocyte trafficking): protect nerve tissue in relapsing MS
relapsing MS · Integrin blockade (lymphocyte trafficking)
Trials have tried this, but none was a controlled phase 2 or 3 trial with a readable result.
- Trials
- 3
- Running now
- 0
- Controlled phase 2/3 trials
- 0
- People in controlled trials
- 0
No controlled trial has reported a result yet.
Other linked trials: 3
Dose comparisons, trials against another medicine, add-on trials, phase 1 and uncontrolled studies. They are listed below but do not set the status.
Trials
Other linked trials: 3
These linked trials do not set the status.
- A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of NatalizumabResult in a paper, not read yet
Phase 4 · 2019 · Not randomised
- PRTOECTStopped, other reason
Phase 4 · 2008 · Not randomised
- Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple SclerosisNo result found
Phase 2 · 2007 · Not randomised
The deciding phase and counts come from the Trial Bank’s fixed rules.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- 2026-10-28Trials: 4 → 3
- 2026-10-27First listed as No clear answer
Related hypotheses
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error